STOUT JAY S (Chief Technology Officer) sold 15.9% of their position (40K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $1.53M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/26/2026ACC: 0001764013-26-000074
Officer· Chief Technology Officer
Since Apr 2023
-40K
Net shares
Net seller
$1.53M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−33.28K
Price / share
$38.18
Trade value
$1.27M
% of position
13.2%
6/26/2026
251.69K→218.41K
Common Stock
Direct
Shares
−6.72K
Price / share
$38.94
Trade value
$261.79K
% of position
3.1%
6/26/2026
218.41K→211.69K
Total
Net shares
−40K
Net value
-$1.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2026 | S · Sale | −33.28K | $38.18 | $1.27M | 13.2% | 251.69K | 218.41K |
| Common Stock Direct | 6/26/2026 | S · Sale | −6.72K | $38.94 | $261.79K | 3.1% | 218.41K | 211.69K |
| Total | −40K | -$1.53M | ||||||
Derivative Transactions0
No derivative transactions reported